Randall Reese
Pediatrics · Gulf Breeze, FLNPI 1285718676
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Among pediatrics clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 142 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$394
- Corium, LLC$338
- Neos Therapeutics, LP$280
- Takeda Pharmaceuticals U.S.A., Inc.$278
- Tris Pharma Inc$233
- Pfizer$142
- plus $875 from 17 others
Across 270 payments — averaging $8462.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$1.5M
- Eli Lilly$494K
- GSK$130K
- Sanofi Pasteur Inc.$76K
- Genentech, Inc.$59K
- Phathom Pharmaceuticals, Inc.$36K
- plus $29K from 2 others
What the payments were for
- Food & beverage$2,48998%
- Education$502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 22 | $394 |
| Corium, LLC | 16 | $338 |
| Neos Therapeutics, LP | 17 | $280 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $278 |
| Tris Pharma Inc | 13 | $233 |
| Pfizer | 10 | $142 |
| Ironshore Pharmaceuticals Inc. | 8 | $128 |
| Sanofi Pasteur Inc. | 7 | $112 |
| GSK | 5 | $92 |
| Collegium Pharmaceutical, Inc. | 5 | $85 |
| Tempus AI, Inc | 3 | $66 |
| Verrica Pharmaceuticals Inc. | 3 | $65 |
| Eli Lilly | 1 | $58 |
| Merck | 3 | $51 |
| Seqirus USA Inc | 2 | $44 |
| Cranial Technologies, Inc | 2 | $37 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Adlon Therapeutics L.p. | 2 | $25 |
| AstraZeneca | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Mission Pharmacal Company | 1 | $13 |
How this compares
$2,539 in reported general payments places this provider in the 95th percentile of 3,964 pediatrics providers in Florida.
Other pediatrics in Gulf Breeze
- Jorge Lujan-ZilbermanTampa$378K
- Bonnie SmeryageHollywood$153K
- Patricia DeanMiami$92K
- Ryan CantvilleJacksonville$87K
- Christina CanodyTampa$87K
- Sofia MirandaMiami$67K
- Jose HerreraMiami$61K
- Joanna DavisMiami$59K
- Anastasia Albanese-O'neillGainesville$42K
- Monica ShahBrandon$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.